FR EN

The company

Introduction

WARNING : In the United States, Ricarimpex leeches may only be used as an adjunct to the healing of graft tissue when problems of venous congestion may delay healing, or to overcome problems of venous congestion by creating prolonged localized bleeding. Leeches have not been cleared by the FDA for any of the applications in general medicine described on this website or in any other source of information on medicinal leeches, scientific or otherwise.

RICARIMPEX, whose origins date back to 1845, is the only French company to specialise in the breeding and marketing of medicinal leeches (Hirudo medicinalis).
ISO 9001-certified (version 2008), RICARIMPEX, which is based in the Gironde region of Western France was also the first company to achieve 510(k) clearance for sale of medicinal leeches as a medical device in the United States for the following indications for use: “As an adjunct to the healing of graft tissue when problems of venous congestion may delay healing, or to overcome problems of venous congestion by creating prolonged localized bleeding.”